📈 Net Income History (16 Quarters)
🧮 CPRX Net Income Breakdown
Understanding Net Income
Net income, also called the "bottom line" or net profit, is the money a company keeps after paying all expenses including cost of goods, operating costs, interest, and taxes. For CPRX, the trailing twelve month net income is $221.3M.
Why Net Income Matters
Net income is the ultimate measure of accounting profitability. It determines earnings per share (EPS), affects stock valuations through the P/E ratio, and represents the theoretical amount available to shareholders. However, net income can be influenced by accounting choices, which is why value investors often look at cash flow metrics alongside it.
CPRX's net income growth rate of 31.95% (based on log-linear regression of 16 quarters) indicates exceptional profit growth, often valued at premium multiples.
Net Income vs Cash Flow Metrics
Free Cash Flow: $208.1M →
Actual cash generated after capital expenditures. FCF often differs from net income due to depreciation, working capital changes, and capex timing.
Owner Earnings: $208.1M →
Buffett's preferred metric that adds back depreciation but subtracts maintenance capex. Often considered more accurate than net income.
EPS (Diluted): $1.73 →
Net income divided by diluted shares outstanding. The primary driver of the P/E ratio used in valuations.
Revenue: $597.0M →
The top line that net income is derived from. Net margin shows what percentage of revenue becomes profit.
P/E Ratio Analysis
CPRX's P/E ratio of 18.2x means investors pay $18.20 for every $1 of annual earnings. A P/E between 15-25 is average for the market, reflecting moderate growth expectations.
Net Margin: Profitability Efficiency
Net margin of 37.08% shows what percentage of CPRX's revenue converts to profit after all costs. Net margins above 20% are excellent and indicate strong pricing power or asset-light business models.
Summary: CPRX Net Income Trend
CATALYST PHARMACEUTICALS, INC. (CPRX) has a net margin of 37.08%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 31.95% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. For complete financial analysis, view the full CPRX stock report on Zyberno.
Frequently Asked Questions
What is CPRX's current net income?
CATALYST PHARMACEUTICALS, INC.'s TTM net income is $221.3M, growing at 31.95% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.
Is CPRX's net income growing?
CATALYST PHARMACEUTICALS, INC. (CPRX) has a net margin of 37.08%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 31.95% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.
What is CPRX's net profit margin?
CATALYST PHARMACEUTICALS, INC. (CPRX) has a net margin of 37.08%, which Zyberno classifies as excellent for a Healthcare company — above the 18% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 31.95% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.
What is CPRX's P/E ratio?
CPRX's P/E ratio is 18.2x, meaning the market values the company at 18.2 times its annual earnings.
How does net income differ from free cash flow?
Net income is an accounting measure that includes non-cash items like depreciation, while free cash flow shows actual cash generated. CPRX's net income is $221.3M versus free cash flow of $208.1M. Large differences often indicate significant capital expenditures or working capital changes.
📊 Full CPRX Stock Report →
See CPRX's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 CPRX Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 CPRX Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 CPRX Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 CPRX Earnings Surprise (SUE) →
See whether CPRX is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 CPRX Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 CPRX Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 CPRX Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 CPRX Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.